|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.3 CHF | +0.86% |
|
+10.31% | -29.26% |
| 23/04 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| 29/02 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Xlife Sciences AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CHF 0.988435 million compared to CHF 1.03 million a year ago. Net income was CHF 14.88 million compared to CHF 14.31 million a year ago.
Basic earnings per share from continuing operations was CHF 2.73 compared to CHF 2.72 a year ago. Diluted earnings per share from continuing operations was CHF 2.08 compared to CHF 2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.26% | 222M | |
| +23.37% | 47.02B | |
| +48.83% | 41.86B | |
| -0.94% | 41.76B | |
| -5.86% | 28.8B | |
| +11.29% | 26.05B | |
| -20.92% | 19.15B | |
| +3.20% | 12.55B | |
| -2.67% | 11.82B | |
| +30.23% | 12.34B |
XLIFE SCIENCES AG 